MENU
+Compare
MEIP
Stock ticker: NASDAQ
AS OF
Jan 22, 04:58 PM (EDT)
Price
$2.86
Change
+$0.03 (+1.06%)
Capitalization
18.46M

MEIP MEI Pharma Forecast, Technical & Fundamental Analysis

a mfactures pharmaceuticals products

Industry Biotechnology
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for MEIP with price predictions
Jan 08, 2025

MEIP in upward trend: price expected to rise as it breaks its lower Bollinger Band on December 23, 2024

MEIP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 39 cases where MEIP's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MEIP's RSI Oscillator exited the oversold zone, of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 03, 2025. You may want to consider a long position or call options on MEIP as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for MEIP just turned positive on January 02, 2025. Looking at past instances where MEIP's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MEIP advanced for three days, in of 245 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Aroon Indicator for MEIP entered a downward trend on January 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MEIP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.742) is normal, around the industry mean (15.017). P/E Ratio (1.094) is within average values for comparable stocks, (88.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.838). MEIP has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.298) is also within normal values, averaging (265.166).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MEIP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MEIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MEIP is expected to report earnings to fall 94.31% to -13 cents per share on August 31

MEI Pharma MEIP Stock Earnings Reports
Q2'23
Est.
$-0.13
Q1'23
Beat
by $0.55
Q4'22
Beat
by $0.22
Q3'22
Beat
by $0.05
Q2'22
Missed
by $0.02
The last earnings report on May 11 showed earnings per share of -231 cents, beating the estimate of -286 cents. With 9.74K shares outstanding, the current market capitalization sits at 18.46M.
A.I. Advisor
published General Information

General Information

a mfactures pharmaceuticals products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
11455 El Camino Real
Phone
+1 858 369-7100
Employees
102
Web
https://www.meipharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OPRX5.410.61
+12.59%
OptimizeRx Corp
CPHI0.220.01
+2.86%
China Pharma Holdings
OPK1.500.03
+2.04%
OPKO Health
TDY480.416.52
+1.38%
Teledyne Technologies
IRT19.160.16
+0.84%
Independence Realty Trust

MEIP and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MEIP has been loosely correlated with GOSS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if MEIP jumps, then GOSS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEIP
1D Price
Change %
MEIP100%
-1.32%
GOSS - MEIP
45%
Loosely correlated
-4.15%
AXON - MEIP
28%
Poorly correlated
+1.97%
FBIO - MEIP
25%
Poorly correlated
-0.53%
ETON - MEIP
25%
Poorly correlated
+5.97%
SYRE - MEIP
25%
Poorly correlated
+8.05%
More